Compare Moderna, Inc. (MRNA) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Starbucks Corp — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Starbucks Corp trades at $104.45 (market cap $119.45B). The key difference: Starbucks Corp is far larger — about 5.1× Moderna, Inc.'s market cap, and Starbucks Corp pays a 2.37% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SBUX | |
|---|---|---|
Market Cap | $23.60B | $119.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $108.37 |
52-Week Low | $22.36 | $78.46 |
Enterprise Value | $19.70B | $142.14B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
